Registered name:
Brimonidin/Timolol Olikla |
|
Registration number | 64/300/21-C |
SUKL code | 0259237 |
Date of first registration / renewal | 15.6.2023 |
Marketing authorisation holder | Olikla s.r.o., Náměstí Smiřických 42, 281 63 Kostelec nad Černými lesy, Czech Republic |
Producer | Rafarm S.A., Thesi Pousi-Xatzi Agiou Louka, TK19002 TO 37 Paiania Attiki, Greece |
Dear Madam, Dear Sir,
Please note that the Olikla website you are accessing is not intended for the general public because it contains expert information on drugs and medical devices, including advertising messages, relating to drugs and medical devices. These messages and information are solely for professionals under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising, as amended, i.e. persons authorised to prescribe or dispense drugs or medical devices (“professionals”).
Please note that if you are not a professional, you risk endangering your health or the health of others if you misunderstand or misinterpret the information obtained, in particular the advertising messages which may be part of this website, or use it for self-diagnosis or the determination of medical treatment, whether in relation to you personally or in relation to others.
I declare that I have acquainted myself with the above advice, including the definition of a professional, and I am aware of the risks a person other than a professional accessing this website is exposed to.
Dear Madam, Dear Sir,
In the previous step, you confirmed you are a professional as defined by Act No. 40/1995 Coll., on Regulation of Advertising, as amended, i.e. that you are a person authorised to prescribe or dispense drugs and medical devices. If your declaration is untrue, please note that you are endangering your health or the health of others.
YES, I declare I am a professional under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising.
NO, I am not a professional under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising.